Reports

Annual Reports

2023: Surgical Therapies Commission Annual Report

2022: Surgical Therapies Commission Annual Report

2021: Surgical Therapies Commission Annual Report

2020: Surgical Therapies Commission Annual Report

2019: Surgical Therapies Commission Annual Report

2018: Surgical Therapies Commission Annual Report

2015: Surgical Therapies Commission Annual Report

2014: Annual Report 2014 - Surgical Therapies Commission | Commission Report

2013: Annual Report | Therapeutics Commission Report

2012: Annual Report

Activity Reports

Epilepsy Surgery Mentoring in Paraguay, Paraguayan League Against Epilepsy (2023)

Guidelines

Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy, Epilepsia (2022)

Neurostimulation in People with Drug-Resistant Epilepsy: Systematic Review and Meta-Analysis from the ILAE Surgical Therapies Commission, Epilepsia (2022)

Establishing criteria for pediatric epilepsy surgery center levels of care: Report from the ILAE Pediatric Epilepsy Surgery Task Force, Epilepsia (2020)

Antiepileptic drug selection for people with HIV/AIDS: Evidence-based guidelines from the ILAE and AAN (2012)

Pregnancy registries: Differences, similarities, and possible harmonization (2010)

Antiepileptic drugs – Best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies (2008)

Definition of Drug-Resistant Epilepsy

The Commission on Therapeutic Strategies charged a Task Force to draft a definition of Drug-Resistant Epilepsy. The resulting report was prepared in 2009 and was published in Epilepsia in 2010. (Epilepsia, 51(6):1069–1077, 2010).

Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE Commission on Therapeutic Strategies, 2009